From HIV to Hormone Therapy, Medicaid Cuts Threaten Atlanta's LGBTQ+ Community
Cooper, a trans woman who serves as the director of strategic outreach and training for the Human Rights Campaign, told Capital B Atlanta that for her and other Black trans residents, these cuts will have a detrimental impact on their lives.
'The Black LGBTQ community will be greatly impacted, and Black trans folks even more so,' said Cooper. 'For years, we've acknowledged how systematic racism impacts the lives of Black LGBTQ people. Inequity and racist ideology and policies have traditionally led to worse health outcomes for poor, less educated, underemployed people and those of us who live in the South.'
Last month, congressional House Republicans passed a bill that would cut billions over the next 10 years from Medicaid, the federal-state health care insurance program that helps pay for health care for low-income people. The bill also would prohibit gender transition care from being covered by the program.
'I worry that preventable health conditions like HIV will ravage my community,' Cooper said. 'I worry that Black trans people will lose some of the social and political traction that our transestors fought for. I worry that my Black trans family will have to go back into the proverbial closet for safety. Closets are made for clothes, not people.'
Cooper worries that in a place like Georgia, where HIV rates are high and access to health care is already difficult due to the Georgia General Assembly's refusal to expand Medicaid, the Black LGBTQ+ community will be one of the vulnerable and bear the brunt of these looming cuts.
In 2023, about 1 in every 4 Black Georgians was covered by Medicaid, compared to about 1 in every 10 white Georgians, according to the State Health Access Data Assistance Center.
Nationally, Black LGBTQ residents are twice as likely to be enrolled in Medicaid compared to the general population, Victoria Kirby York, director of public policy and programs for the National Black Justice Coalition, told Capital B Atlanta.
York said she's fearful that critical areas of health care for Black LGBTQ+ residents such as gender-affirming care, mental health services, and substance abuse treatment will all be impacted by the Medicaid cuts.
'Thirty-two percent of [LGBTQ people] versus 15% of the general population use Medicaid in order to access health care, and that number is even higher for transgender members of our community, where 45% of the community are relying on Medicaid,' York said.
Although Georgia is one of the 10 states that did not expand Medicaid, leaving hundreds of thousands of residents uninsured, the proposed budget cuts will still be felt. The state could potentially lose billions in federal Medicaid funding, and hundreds of thousands of Georgians could lose Medicaid coverage over the next 10 years, according to reporting from the Kaiser Family Foundation.
Matthew Rose, senior public policy advocate with the Human Rights Campaign, told Capital B Atlanta these cuts will put a strain on the state's budget, resulting in a push by state lawmakers to make 'draconian' decisions on how to further cut costs.
This could mean cutting back on some of the optional health services and medicines provided underneath Medicaid in Georgia, such as HIV preventative medications or mental health services, or lawmakers could tighten eligibility requirements so fewer residents are covered by the insurance program.
When it comes to HIV, Maxx Boykin, the campaign manager for Save HIV Funding, told Capital B Atlanta he worries Medicaid cuts could exacerbate the already high HIV transmission rates in the state, as many people living with HIV rely on Medicaid for medication and wraparound services like home health care and therapy.
Read More: CDC Cuts HIV Communications, Leaving Vulnerable Black Georgians in the Dark
According to the Kaiser Family Foundation, Medicaid is the largest source of insurance coverage for people with HIV in the United States, covering an estimated 40% of the nonelderly adults with HIV, compared to just 15% of the nonelderly adult population overall.
According to the CDC, Georgia had the second-highest HIV diagnosis rate and the second-highest rate of HIV related deaths in 2023 in the U.S.
Additionally, Georgia had the highest rate of new HIV infections in 2022. In addition, despite constituting about 32% of Georgia's population, Black people accounted for approximately 71% of new HIV diagnoses in 2021.
'When thinking about HIV, that means less people will have access to the medications that they need, and we will see an even larger spread of HIV in our communities, and a big part of that will be because the majority of people living with HIV actually need Medicaid,' said Boykin.
Maisha Standifer, the director of population health at the Satcher Health Leadership Institute at the Morehouse School of Medicine, said the elderly and those with disabilities shouldn't be forgotten when thinking about Medicaid and the LGBTQ community.
According to the Human Rights Campaign, in the U.S., LGBTQ+ adults, and transgender adults in particular, were significantly more likely than non-LGBTQ+ adults to self-report having at least one disability.
Standifer said that for Georgia's Medicaid program, people ages 65 and older and people with disabilities account for more than half of the state's $16 billion Medicaid spending.
'We have community partners who are 30-plus years living with HIV and aging. So with aging naturally comes other chronic conditions. We're talking about diabetes, cancer, heart disease,' said Standifer.
The cuts to Medicaid are part of the Trump administration's efforts to curb federal spending to offset the cost of extending the president's 2017 tax cuts for high-income earners.
Of further concern to Rose with the Human Rights Campaign is the impact on the LGBTQ community when the Medicaid cuts are layered on top of the proposed SNAP cuts in the bill, creating even more harm to LGBTQ people's health.
'We've seen the result of what hunger can do, which is why we feed people, why we created these programs in the first place, and the SNAP cuts would be devastating. … Then you tack them on to the fact that you're not eating as much, which weakens your immune system, and so it makes it easier for you to get sick, so it's a compounding issue,' said Rose.
While the Medicaid cuts are still under review in the Senate, advocates are encouraging anyone in opposition to the cuts to reach out to their representatives and share their concerns about the proposed legislation.
'We need to hold our elected officials accountable, both on the federal side, the state side, and our local side, to make sure they're actually doing what's right for folks,' said Boykin.
The post From HIV to Hormone Therapy, Medicaid Cuts Threaten Atlanta's LGBTQ+ Community appeared first on Capital B News - Atlanta.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Newsweek
7 minutes ago
- Newsweek
Medicare Update: Trump Admin Launching Pilot Program to Cover Ozempic
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. The Trump administration is preparing a five-year pilot program that would allow Medicare and Medicaid to cover some of the most in-demand weight-loss drugs, a move that could transform obesity treatment for millions of Americans. The plan, which includes medications such as Ozempic, Wegovy, Mounjaro and Zepbound, represents a reversal in federal policy and signals a broader willingness to use public insurance to address the nation's obesity epidemic. Why It Matters The drugs, known as GLP-1 receptor agonists, were initially developed to treat Type 2 diabetes but have become a cultural phenomenon for their ability to suppress appetite and help patients lose as much as 20 percent of their body weight in clinical trials. The pilot builds on a proposal introduced in the final months of the Biden administration but shelved earlier this year when officials under President Donald Trump announced Medicare and Medicaid would not cover weight-loss medications. What To Know According to documents obtained by The Washington Post, the program would allow state Medicaid programs and Medicare Part D plans to voluntarily cover GLP-1 drugs for weight management. The initiative is scheduled to begin in April 2026 for Medicaid and January 2027 for Medicare and will be administered through the Center for Medicare and Medicaid Innovation, which tests new payment models designed to reduce costs and improve care. Chiquita Brooks-LaSure, who led the Centers for Medicare and Medicaid Services under former President Joe Biden, told the Post the experiment would be a "game changer" if it expands access to obesity treatments. "Increased coverage of anti-obesity medications in Medicare and Medicaid was a priority during my tenure because scientists and clinicians increasingly believe obesity is a serious health condition that should be treated accordingly," she said. A pharmacy owner displays an Ozempic package in Pristina, Kosovo, on March 27. A pharmacy owner displays an Ozempic package in Pristina, Kosovo, on March 27. Photo by ARMEND NIMANI/AFP via Getty Images The program faces a major hurdle: price. GLP-1 drugs typically cost from $5,000 to $7,000 a year, raising questions about whether widespread coverage is sustainable. "The short-term cost is still huge," Dr. Cynthia Cox, vice president at KFF (formerly Kaiser Family Foundation), told Newsweek. "$1,000 a month per person is a massive outlay." A KFF analysis found that Ozempic's U.S. list price is $936 a month—more than five times the cost in Japan, where it sells for $169. Wegovy, which contains the same active ingredient, costs roughly $1,349 a month in the U.S., compared to $328 in Germany. At the moment, 13 state Medicaid programs cover GLP-1 drugs for obesity. Medicare limits coverage to patients with related conditions such as diabetes or heart disease. With about 70 million people enrolled in Medicaid and 65 million in Medicare, even partial expansion could affect a significant share of the population. Ethicists warn of the potential economic fallout. "These drugs help over 50 percent of people lose up to 25 percent of their body weight," said Dr. Robert Klitzman, a Columbia University bioethicist, in an interview with Newsweek. "But they cost around $12,000 a year. If two-thirds of Americans needed them, it would bankrupt the health care system." Despite the financial concerns, GLP-1 medications are generating enthusiasm among doctors for their ability to improve multiple health markers beyond weight loss. Clinical trials show they can reduce blood sugar, lower blood pressure and improve cardiovascular outcomes. "Ozempic and other GLP-1 drugs are changing how we approach obesity, both in the doctor's office and for society in general," Dr. Raj Dasgupta, chief medical adviser for Garage Gym Reviews, told Newsweek. "They're helping shift the conversation from 'this is a personal failure' to 'this is a medical condition that deserves real treatment.'" The Congressional Budget Office estimates that adding obesity coverage could cost Medicare $35 billion from 2026 to 2034. What People Are Saying A spokesperson for Novo Nordisk, which manufactures Ozempic and Wegovy, told The Washington Post: "We believe that comprehensive coverage through government and commercial insurance plans is critical to affordable health care and treatment options." Klitzman also said in the interview with Newsweek: "Insurance doesn't always cover it, especially for people who don't have diabetes or heart disease. Initially, the drugs were approved for diabetes-related obesity, but doctors have been prescribing them to people who are just overweight, without those conditions." What Happens Next With more than 100 million U.S. adults classified as obese and 22 million considered severely obese, according to the Centers for Disease Control and Prevention, the program's potential impact is vast. The proposal is not final and could undergo a formal public comment period before implementation.


CBS News
7 minutes ago
- CBS News
Minnesota DHS moves to terminate housing stability program amid fraud investigation
The Minnesota Department of Human Services says it's making moves to terminate the Housing Stabilization Services program as federal authorities investigate fraud tied to the program. DHS' Temporary Commissioner Shireen Gandhi wrote a letter Friday to the federal Centers for Medicare and Medicaid Services requesting to end the program. Housing Stabilization Services is a newer Minnesota Medical Assistance benefit meant to help find and maintain homes for people with disabilities or the elderly. But a search warrant filed earlier this month in the U.S. District Court of Minnesota details a "massive scheme to defraud" the program. "DHS is rooting out fraud wherever we find it. We cannot allow one more cent of taxpayer money going out the door to providers who claim to serve Minnesotans in need of stable housing while lining their pockets for personal gain," said DHS Temporary Commissioner Shireen Gandhi. "As I made clear in my letter to CMS, our own data analysis has shown that this program does not have the necessary controls to stop bad actors, and we are urging CMS to approve our request to end this program as swiftly as possible." What was originally estimated in 2020 to cost taxpayers about $2.5 million a year ended up costing $104 million in 2024. The FBI in the warrant called the housing program "extremely vulnerable to fraud." Earlier this week, Gov. Tim Walz said he'd stopped payments to 50 program recipients. DHS said it has since issued 11 payment withholds to HSS providers. DHS Inspector General James Clark said a data analysis revealed "too many fraudulent, unqualified bad actors have likely stolen money from our state's taxpayers, and also cheated Minnesotans who need housing services." The human services department added that it intends to redesign and relaunch the benefit, working with the legislature and providers to create a robust program.


The Hill
36 minutes ago
- The Hill
Congressional Hispanic Caucus chair accuses Texas Republicans of silencing Latino voters with redistricting plan
Congressional Hispanic Caucus Chair Adriano Espaillat (D-Texas) accused Texas Republicans of silencing Latino voters with their proposed redistricting plan in a letter first obtained by The Hill on Friday. In a letter addressed to J.M. Vasut, chair of the Texas Committee on Redistricting, and the committee's Jon Rosenthal, Espaillat described the new congressional map proposed by Texas Republicans as 'a blatant power grab that undermines democracy and silences Latino voters.' Espaillat specifically noted that in Harris County, where Latinos make up 46 percent of the population, Texas Republicans have slashed the Hispanic Voting Age population in the 29th congressional district from 65.5 percent to 43 percent. 'Across the state, Republicans are using surgical precision to redraw maps and erode minority voting strength,' Epaillat wrote. 'The goal is not fairness, it's submission—to Trump, to extremism, and to a toxic political agenda that enriches the powerful while working families, children, seniors, and veterans are left behind. This redistricting scheme would be more at home under a dictatorship than in a functioning democracy.' Rep. Sylvia Garcia (D-Texas) presented the letter while testifying in the Texas state House Select Committee on Congressional Redistricting. Espaillat's letter comes as the committee is gearing up to vote on the proposed House map, which would create five new House seats that President Trump won by double digits in November. President Trump had called on the state's Republicans to redraw the lines to protect the party's narrow 219-212 House majority in the 2026 midterms.